Search

News & Events

Jake's diabetes journey Age when diagnosed; two years-old, almost three.

News & Events

JRDF One Walk

Patients, families and our centre staff members took part in JDRF's One Walk last October to raise funds for type 1 diabetes research.

News & Events

For all of our budding young actors…

We are looking to create exciting new online resources for our families to utilise, which will include how-to videos, as well as patient perspective interviews.

News & Events

Interested in insulin pump therapy but not too sure where to start?

Here's a brief guide on how to apply for insulin pump therapy.

News & Events

Diabetes Australia app

Diabetes Australia have released an app to make living with or caring for someone with diabetes a little easier.

Privacy Policy

Privacy Policy // <![CDATA[ (function (w,d) {var loader = function () {var s = d.createElement("script"), tag = d.getElementsByTagName("script")[0]; s.src = "https://cdn.iubenda.com/iubenda.js"; tag.parentNode.insertBefore(s,tag);}; if(

Be involved

Find out how to participate in our research and community groups.

Research

Feasibility and acceptability of implementing an evidence-based ESCALATION system for paediatric clinical deterioration

The ESCALATION system is a novel paediatric Early Warning System that incorporates family involvement and sepsis recognition. This study aimed to assess the feasibility and iteratively refine the ESCALATION system in a variety of hospital settings in preparation for full-service implementation.

Research

Socioeconomic representativeness of Australian, Canadian and British cohorts from the paediatric diabetes AdDIT study: comparisons to regional and national data

Given limited data regarding the involvement of disadvantaged groups in paediatric diabetes clinical trials, this study aimed to evaluate the socioeconomic representativeness of participants recruited into a multinational clinical trial in relation to regional and national type 1 diabetes reference populations.

Research

Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: Advantages, limitations, and comparisons with laboratory-based testing

Type 1 diabetes is well-recognised as a continuum heralded by the development of islet autoantibodies, progression to islet autoimmunity causing beta cell destruction, culminating in insulin deficiency and clinical disease. Abnormalities of glucose homeostasis are known to exist well before the onset of typical symptoms.